Going to the Dogs: Pets and Owners Share Resistant Pathogens

Dogs’ gastrointestinal tracts may be an important reservoir of antibiotic-resistant E coli of public health concern, including strains that have been associated with human extra-intestinal infections. Medscape Medical News

Can You Tell if Your Patients Can’t Make Decisions?

Dr. Charles P. Vega reviews a study and a useful tool for assessing patient incapacity to make informed medical decisions. Medscape Family Medicine

Transfers Not Good for Nursing Home Dementia Patients (CME/CE)

(MedPage Today) — Advanced dementia patients commonly go through potentially unnecessary and difficult transitions from the nursing home to other care settings in their last months of life, researchers found.

Healthcare Reform Law Reaches Supreme Court

WASHINGTON (MedPage Today) — The Obama administration filed a petition Wednesday with the Supreme Court asking for a speedy ruling on the constitutionality of the Affordable Care Act.

Two NSAIDs Have Better CV Profile than Others (CME/CE)

(MedPage Today) — Although there is an established cardiovascular risk associated with nonsteroidal anti-inflammatory drugs, two of them — naproxen and low-dose ibuprofen — carry a lower risk than the others, an analysis of observational studies found.

Listeriosis Deaths Climb to 13 in ‘Deadliest’ Outbreak

(MedPage Today) — The listeriosis outbreak stemming from tainted cantaloupes has sickened at least 72 individuals, killing 13 of them, according to the CDC.

‘Baby Joseph’ Dies at Home

(MedPage Today) — “Baby Joseph,” the Canadian infant with a rare but terminal neurological disease whose treatment sparked a national controversy, died Tuesday in his Windsor, Ontario, home at 20 months of age.

Medicare to Test Incentive Pay for Primary Care Docs

WASHINGTON (MedPage Today) — Starting next summer, a Medicare pilot project will pay primary care practices in select areas an extra $20 a month per patient for making themselves more available to patients and otherwise personalizing care.

Positive new data from Otonomy’s OTO-104 Phase 1b study on Meniere’s disease

Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced that researchers presented positive new data from a Phase 1b study of the company’s lead product candidate, OTO-104, in patients with Meniere’s disease.

Cubist plans to move CB-183,315 into Phase 3 trial for treatment of CDAD

Cubist Pharmaceuticals, Inc. today announced it plans to move CB-183,315, being studied for the treatment of a severe and sometimes life-threatening diarrhea caused by Clostridium difficile known as C. difficile-associated diarrhea, or CDAD, into late-stage trials.